Does accounting for seizure frequency variability increase clinical trial power?

Daniel M. Goldenholz(Beth Israel Deaconess Medical Center), Carl F. Pieper(Duke University), Jacqueline A. French(Epilepsy Foundation), John Hixson(UCSF Benioff Children's Hospital), Shira R. Goldenholz(Beth Israel Deaconess Medical Center), Mark Cook(St Vincent's Hospital Melbourne), Robert Moss(College Track), William H. Theodore(National Institute of Neurological Disorders and Stroke), Sabrina Cristofaro(New York University), Philippa J. Karoly(The University of Melbourne), Alex Strashny(The Centers), Ruben Kuzniecky(Northwell Health), Daniel H. Lowenstein(UCSF Benioff Children's Hospital), Sheryl R. Haut(Albert Einstein College of Medicine), Kamil Detyniecki
Epilepsy Research
July 25, 2017
Cited by 30


Related Papers